Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology
|
Buy Now
Immunotherapy (Hardcover, 4th ed. 2021)
Loot Price: R6,051
Discovery Miles 60 510
|
|
Immunotherapy (Hardcover, 4th ed. 2021)
Series: Advances in Experimental Medicine and Biology, 1342
Expected to ship within 12 - 17 working days
|
The field of immuno-oncology continues to rapidly evolve as new
insights to fight and treat cancer emerge. The fourth edition of
Immunotherapy provides the most current overview of immuno-oncology
in different cancer types and toxicities associated with
immunotherapy. While immunotherapy has revolutionized the treatment
landscape of several solid malignancies, several challenges still
exist. Only a subset of patients derive clinical benefits; some do
not respond at all, and others respond initially, only for their
disease to progress later. Because these drugs can activate a broad
range of immune cells, patients suffer from a unique set of side
effects known as immune-related adverse events. As more
immunotherapeutic agents are used in the clinic, it is important to
provide updates about current and ongoing developments in the field
to further research efforts and inform treatment decisions. The
fourth edition will have a new focus on strategies to overcome the
challenges associated with immunotherapy. Chapters will discuss
topics such as biomarkers of response, resistance mechanisms, role
of imaging in predicting immune-related adverse events, and
management of immune-related adverse events. Written by leading
experts conducting cutting-edge research, readers will gain
up-to-date knowledge on the current state and future of
immunotherapy.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.